Tag: Abraxane

October 2, 2018

Rexahn Pharmaceuticals Presents Preliminary Safety and Efficacy Data From Ongoing Phase 2a Clinical Trial

Rexahn Pharmaceuticals (NYSE:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced preliminary...
May 7, 2018

Rexahn Reports First Quarter 2018 Financial Results

Rexahn Pharmaceuticals (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, announced financial...
April 10, 2017

OncoMed's Stocks Slip As Cancer Trial Gets Pulled

The company's share price took a 40 percent hit following its announcement that its midstage pancreatic cancer trial missed its...